INGREZZA - For the treatment of chorea associated with Huntington's Disease (HD) TOOLKIT & RESOURCESkatrina4384Sep 26, 20231 min readFind out more here:INGREZZA HDC Launch Toolkit_FINAL.pdf
Sarepta Therapeutics Announces Submission of Clinical Trial Application for SRP-1005, its Investigational Treatment for Huntington’s Disease
‘Ready to fight the fight’: Huntington’s disease community delivers petitions to FDA seeking approval of uniQure gene therapy - By Gene Veritas
Comments